Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
31 mars 2024 19h00 HE
|
Curative Biotechnology, Inc.
Palm Beach Gardens, FL, and Tokyo, Japan, March 31, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company...
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
22 mars 2024 09h45 HE
|
Curative Biotechnology, Inc.
Palm Beach Gardens, FL, March 22, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel...
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors
31 oct. 2023 09h45 HE
|
Curative Biotechnology, Inc.
Appointment of Independent Director to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology...
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions
06 juin 2023 09h50 HE
|
Curative Biotechnology, Inc.
Appoints Paul Michaels Co-CEO of Parent and CEO of Subsidiary Boca Raton, FL, June 06, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a...
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation
24 mai 2023 10h12 HE
|
Curative Biotechnology, Inc.
Topical Administration Capable of Delivering Metformin to Choroid, RPE, and Retina Boca Raton, FL, May 24, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or...
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study
05 janv. 2023 07h50 HE
|
Curative Biotechnology, Inc.
Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments...
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange
27 sept. 2022 07h00 HE
|
Curative Biotechnology, Inc.
Boca Raton, FL, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments...
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors
16 juin 2022 09h50 HE
|
Curative Biotechnology, Inc.
Appointment of Independent Director Builds Upon Biotech Expertise Boca Raton, FL, June 16, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a...
Curative Biotechnology, Inc. Appoints Marc Drimer, CPA to Board of Directors as Independent Director and Chairman of Audit Committee
15 juil. 2021 10h00 HE
|
Curative Biotechnology, Inc.
Boca Raton, FL, July 15, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development stage biomedical company focused on novel therapies for...